Thirty Day Resource Utilization after Chimeric Antigen Receptor (CAR) T Cell Infusion for Hematologic Malignancies

被引：0

作者：

Shah, Gunjan L. ^{[1
]}

Park, Jae ^{[2
]}

Sauter, Craig S. ^{[1
]}

Duck, Elaine ^{[3
]}

Halton, Elizabeth ^{[4
]}

Batlevi, Connie W. ^{[5
]}

Palomba, M. Lia ^{[5
]}

Younes, Anas ^{[5
]}

Geyer, Mark B. ^{[2
]}

Smith, Eric ^{[6
]}

Mailankody, Sham ^{[6
]}

Mead, Elena ^{[7
]}

Santomasso, Bianca ^{[8
]}

Perales, Miguel-Angel ^{[9
]}

Sabbatini, Paul ^{[10
]}

Giralt, Sergio A. ^{[9
]}

Brentjens, Renier ^{[2
]}

Bach, Peter B. ^{[11
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, 1275 York Ave, New York, NY 10021 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA

[3] Mem Sloan Kettering Canc Ctr, Managed Care Outcomes Anal, 1275 York Ave, New York, NY 10021 USA

[4] Mem Sloan Kettering Canc Ctr, Cellular Therapeut Ctr, 1275 York Ave, New York, NY 10021 USA

[5] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA

[6] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA

[7] Mem Sloan Kettering Canc Ctr, Dept Anesthesiol & Crit Care Med, 1275 York Ave, New York, NY 10021 USA

[8] Mem Sloan Kettering Canc Ctr, Dept Neurol, Brain Tumor Serv, 1275 York Ave, New York, NY 10021 USA

[9] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[10] Mem Sloan Kettering Canc Ctr, Gynecol Med Oncol Serv, 1275 York Ave, New York, NY 10021 USA

[11] Mem Sloan Kettering Canc Ctr, Ctr Hlth Policy & Outcomes, 1275 York Ave, New York, NY 10021 USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2

共 50 条

[31] Chimeric Antigen Receptor (CAR) T-cell therapy; a promising outlook for refractory malignancies
Haider, Syed Ali
Tariq, Syed Maaz
Hasan, Mohammad
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2018, 68 (09) : 1422 - 1423
[32] Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in hematologic malignancies: a living systematic review on comparative studies
Saiz, Luis Carlos
Leache, Leire
Gutierrez-Valencia, Marta
Erviti, Juan
Reyes, Maria Ximena Rojas
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2023, 14
[33] Neurocognitive Performance Changes with Chimeric Antigen Receptor T-Cell Therapy in Patients with Hematologic Malignancies
Giri, Smith
Giri, Smith
Ubersax, Clare
Tucker, Abigail
Bal, Susan
Godby, Kelly
Costa, Luciano
Bhatia, Smita
Williams, Grant
Ravi, Gayathri
Narkhede, Mayur
Murdaugh, Donna
BLOOD, 2023, 142
[34] Strategies to optimize chimeric antigen receptor T-cell therapy in hematologic malignancies: Chinese experience
Sun, Wei
Liang, Ai-Bin
Huang, He
Huang, Xiao-Jun
HAEMATOLOGICA, 2023, 108 (08) : 2011 - 2028
[35] Early cytopenias and infections following chimeric antigen receptor T-Cell therapy for hematologic malignancies
McGann, Mary
Velayati, Arash
Roubal, Kiera
Granger, Katelynn
Davis, James A.
Gaffney, Kelly J.
Weeda, Erin
Hashmi, Hamza
LEUKEMIA & LYMPHOMA, 2023,
[36] Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies
Jain, Tania
Knezevic, Andrea
Pennisi, Martina
Chen, Yunxin
Ruiz, Josel D.
Purdon, Terence J.
Devlin, Sean M.
Smith, Melody
Shah, Gunjan L.
Halton, Elizabeth
Diamonte, Claudia
Scordo, Michael
Sauter, Craig S.
Mead, Elena
Santomasso, Bianca D.
Palomba, M. Lia
Batlevi, Connie W.
Maloy, Molly A.
Giralt, Sergio
Smith, Eric
Brentjens, Renier
Park, Jae H.
Perales, Miguel-Angel
Mailankody, Sham
BLOOD ADVANCES, 2020, 4 (15) : 3776 - 3787
[37] Characterizing inclusion and exclusion criteria in clinical trials for chimeric antigen receptor (CAR) T-cell therapy among adults with hematologic malignancies
Jaggers, Jordon L.
Giri, Smith
Klepin, Heidi D.
Wildes, Tanya M.
Olin, Rebecca L.
Artz, Andrew
Wall, Sarah
Jaglowski, Samantha
William, Basem
Benson, Don M.
Rosko, Ashley E.
JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (02) : 235 - 238
[38] Coagulation Disorders after Chimeric Antigen Receptor T Cell Therapy: Analysis of 100 Patients with Relapsed and Refractory Hematologic Malignancies
Wang, Ying
Qi, Kunming
Cheng, Hai
Cao, Jiang
Shi, Ming
Qiao, Jianlin
Yan, Zhiling
Jing, Guangjun
Pan, Bin
Sang, Wei
Li, Depeng
Wang, Xiangmin
Fu, Chunling
Zhu, Feng
Zheng, Junnian
Li, Zhenyu
Xu, Kailin
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (05) : 865 - 875
[39] Underrepresentation of Racial and Ethnic Minorities in Registrational Chimeric Antigen Receptor (CAR) T-Cell Therapy Trials in Hematologic Malignancies: An FDA Analysis
Mahat, Upendra
Seam, Pamela
Bouchkouj, Najat
Sharma, Poornima
Peredo-Pinto, Helka
Elmacken, Mona
Kaushal, Megha
Wang, Shu
Xu, Zhiheng
Jia, Yuxia
Richardson, Nicholas
Kanapuru, Bindu
Kasamon, Yvette
Gormley, Nicole
BLOOD, 2023, 142
[40] PREDICTORS FOR NEUROTOXICITY ON DAY OF INFUSION OF CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS USING DISCOVERY PROTEOMICS PLATFORM
Lakkaraja, M.
Hosszu, K.
Mcavoy, D.
Mauguen, A.
Purdon, T. J.
Auchincloss, T.
Klein, E.
Khakoo, Y.
Santomasso, B.
Senechal, B.
Riviere, I.
Sadelain, M.
Curran, K. J.
Park, J.
Brentjens, R. J.
Boelens, J. J.
CYTOTHERAPY, 2021, 23 (05) : S99 - S99

← 1 2 3 4 5 →